Influx constant Clinically isolated syndrome CIS CD14 Demyelination Post-partum Autoimmune diseases ERRα Neuromyelitis optica Neural antibodies Innate immune system CRMP5 Longitudinally extensive transverse myelitis Rituximab MOG antibodies Cannabinoid receptor type 2 Endocannabinoid system Biobank Bone Astrocyte Prognosis Relapses Amino acid MOG-IgG associated disorders MOGAD Cannabinoid receptor type 2 Endocannabinoid system Microglia Neuroinflammation Optic neuritis Aquaporin-4 antibody Connexins LAT1 Blood–brain barrier Aquaporin-4 antibodies Toll-like receptor CP Neuroscience MOG Glutamate Estradiol Circadian clock Myelitis MRI B cells Blood–CSF barrier Cancer immunotherapy Collapsing response mediator protein Children Glia Cerebrospinal fluid Cytokines Bright Immune checkpoint inhibitors Reproductive assistance Disease modifying treatments Animal model Adult neurogenesis MOGAD Lateral diffusion GSK-3β Autoantibodies Neuraxial analgesia Pregnancy Gunn Registry Anti-GFAP encephalomyelitis Autoimmune encephalitis Treatment response Database Breastfeeding Choroid plexus Adverse events Encephalitis Aquaporin-4-IgG AQP4-IgG Meninges Multiple sclerosis Disease-modifying treatments Cilia Blood-brain barrier Ependymal cell neuromyelitis optica aquaporin-4 cilia sub-ventricular zone Myelin oligodendrocyte glycoprotein Immunosuppressant GABA Biomarkers Microenvironment Drosophila Embryo NMOSD Multiple sclerosis MS Jaundice Area postrema syndrome Hippocampus Central nervous system Neurite outgrowth Blood brain barrier Microglia Neuroinflammation Blood-brain barriers CP Molecular biology Claudin Aquaporin-4 COVID-19 Cancer Ependymal cell Neurological immune-related adverse events